Limited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality

نویسندگان
doi
10.18502/cjn.v21i4.11724
چکیده

کلیدواژه‌ها
Mehri Salari1, Sepand Tehrani-Fateh2, Zahra Aminzade2, Masoud Etemadifar3, Parkinsonian Disorders, Mortality, COVID-19